a subgroup of those treated with persistent vulnerability to contract subsequent serious infections. Get the article here
Aagaard et al has developed algorithms able to reliable patients at risk of febrile neutropenia – in press. Future research efforts to better understand the biological mechanisms explaining the vulnerability are required.
The next PERSIMUNE Immunologic Colloquium will take place on 28 November 2018 15:30-16:30 at Rigshospitalet Department of Infectious Diseases. Come and hear about Immunotherapy for cancer by Prof Inge Marie Svane and Big data: ethical implications by Prof Gorm Greisen.
We are looking for a full time programmer for international health research projects in CHIP & PERSIMUNE.
Deadline for application 18th October at 12.00.
Read more about the position and apply here
Rapid estimation of severity of new pandemic influenza types is essential to gauge appropriate level of intervention; the some severe the more intense the intervention. During the 2009 pandemic, Mexican authorities reported substantial severity expressed as a high case fatality rate. In this report, prof Lone Simonsen from CHIP/PERSIMUNE at Righospitalet uses data from a global cohort study lead by INSIGHT to estimate this rate, and find that it was 16 fold lower than initial estimates. These observations can be used to more reliable assess severity in next influenza pandemic. Find the full publication here
The next Immunologic Colloquium will take place 18 April 2018 15.30-16.30 at Rigshospitalet Department of Infectious Diseases.
The course is for people working in health care settings, academic environments, industry and governmental and non-governmental organisations who wish to achieve a basic understanding of, and be able to interpret, cost effectiveness analyses in the context of infectious diseases, with particular focus on HIV
The next Immunologic Colloquium will take place 21 June, 15.30-17.30
Department of Infectious Diseases 8632, Library room 3rd floor
Please find agenda here
Read the latest PERSIMUNE publication
Sustainable HIV treatment in Africa through viral-load-informed differentiated care. L Vojnov et al.
DR TV Avisen
Latest News Link
Read all press coverage of the START Study results here
Read the article on the groundbreaking reults of the START Study, on the benefits of early antiretroviral treatment. Now available online
Follow the live streaming from IAS2015 press conference for the presentation of the groundbreaking results from the START study
Presented by Jens Lundgren, Rigshospitalet, University of Copenhagen, Denmark
The latest PERSIMUNE Newsletter is online. Read more about news and developments here
Read the latest PERSIMUNE publication
Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infection
Article on how Amanda Mocroft and colleagues provide a HIV-specific risk score to balance the potential benefits and harms of nephrotoxic ART, based on data from the DAD study. Addressing the need for personalized decision making in the clinic. Read the article
The PERSIMUNE Informed Consent Form is now available in 10 languages:
Danish, English, Arabic, Farsi, Greenlandic, Faroese, Bosnian, Urdu, Somali and Turkish
Copenhagen Summer University
A 5 day course in Personalised Medicine - the future treatment paradigm 17th-21st August. Dealine for registration is 28th of May.
Read more about the course and sign up here
Copenhagen Summer University for working professionals
Read the latest Newsletter for updates on PERSIMUNE
Newsletter 23 April
The first PERSIMUNE article is on the cover of PLoS Medicine "Development and Validation of a Risk Score for Chronic Kidney Disease in HIV infection Using Prospective Cohort Data from the D:A:D study"
An open access tool to calculate individual patient risk of chronic kidney disease was released in conjunction with the publication of the article
PERSIMUNE has now received approval from the National Danish Data Authorities to commence the recruitment of patients prospectively into the PM platform incl enrolment into the PM biobank. Find Informed Consent Form and Guidance on how to start enrolment here
The PERSIMUNE Project Proposal Form is now available on the website
Newsletter 24 February
START (RCT, n=4685) examines influence of immunosuppression on clinical outcomes - here is an exhaustive description of the cohort at study entry - trial results expected by end 2016
PERSIMUNE communicates through social media to increase awareness about the new research platform and to share and disseminate findings, events and more. We encourage feedback, discussion and knowledge sharing via social media. Read more on why and how here Social Media guide.pdf
Agenda for PERSIMUNE Scientific retreat 3rd and 4th February.
Programme for official opening of PERSIMUNE
The official opening ceremony of PERSIMUNE will take place on 4th February 2015 at 14:30, Øster Allé 56, 5th floor. All are welcome! Kindly reply to: email@example.com
For more information please click here
Newsletter 25 October 2014